For many patients medicines remain inaccessible due to high prices. That is why we decided to develop specialty generic medicines, in order to offer patients a cheaper alternative and allow wider access to effective treatment. We develop high-quality generic products for markets in the US, Europe, Asia and other countries around the world. Providing quality products through scientific innovations, diligence and precision is the goal of all our research programs.

Different Dosage Forms

Dosage forms include immediate release (IR), modified release (MR) [extended release(ER), Delayed Release(DR)] dosage forms of tablets, capsules, liquids, suspensions, injectable and transdermal.

  • We control quality of active ingredients and raw materials from initial stage of manufacturing our high quality products.

  • Wide range of prescription and over-the counter products including tablets, capsules, liquids, suspensions, injectables, and transdermal.

  • Providing quality products through scientific innovations, diligence and precision is the goal.

  • Develops high-quality generic products for global markets.

Technologies used

This process is particularly for a controlled release of active ingredients. In the Wurster process, a complete sealing of the surface can be achieved with a low usage of coating substance. 

Direct pelletizing permits pellets to be made directly from powder ingredients. Their regular form and surface are extremely suitable for applying even film, such as needed for a controlled release of active ingredients.

Treatment of many diseases requires a dosage regimen that delivers acceptable therapeutic concentrations of the drug at the site of action, which can be attained immediately and then constantly maintained over the desired duration of treatment.

Osmotically controlled oral drug-delivery systems releases drugs in zero-order kinetics

  • The drug is delivered at a constant rate that is independent of time and drug concentration.
  • The release rate is highly predictable.
  • Higher release rates are possible compared with conventional drug-delivery systems.
  • Drug release is independent of physiological factors of the gastrointestinal tract, including gastric pH and hydrodynamic conditions.
  • Drug release is generally not affected by the presence of food.
  • The release rate can be programmed by modulating release-control parameters.
  • Delivery may be delayed or pulsed if desired.

Bilayer tablets can be a primary option to enable different drug release profiles (immediate release with control release) and to avoid chemical incompatibilities between API by physical separation

Mini-tabs are typically less than 3 mm that are filled into a capsule. It is possible to incorporate different mini-tablets, each one formulated individually and programmed to release drug at different sites. These combinations may include immediate release, delayed release, and/or controlled release mini-tabs.